APA (7th ed.) Citation

Marcello Lanari, Elisabetta Venturini, Luca Pierantoni, Giacomo Stera, Guido Castelli Gattinara, Susanna Maria Roberta Esposito, . . . Other Collaborators. (2022). Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: An Italian inter-society consensus statement. BMC.

Chicago Style (17th ed.) Citation

Marcello Lanari, et al. Eligibility Criteria for Pediatric Patients Who May Benefit from Anti SARS-CoV-2 Monoclonal Antibody Therapy Administration: An Italian Inter-society Consensus Statement. BMC, 2022.

MLA (9th ed.) Citation

Marcello Lanari, et al. Eligibility Criteria for Pediatric Patients Who May Benefit from Anti SARS-CoV-2 Monoclonal Antibody Therapy Administration: An Italian Inter-society Consensus Statement. BMC, 2022.